Clinical Trials Directory

Trials / Completed

CompletedNCT01240174

Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

Studies show, guidelines state, and performance measures assert that antibiotic prescribing for uncomplicated acute bronchitis is inappropriate. However, clinicians prescribe antimicrobials in over 60% of the 22.5 million acute bronchitis visits in the United States each year. Previous successful interventions have only reduced the antimicrobial prescribing rate to 40% or 50%. It is unknown if the antimicrobial prescribing rate for acute bronchitis can be brought to near zero percent in actual practice while maintaining patient safety and satisfaction. The goal of this study is to develop an Electronic Health Record (EHR)-integrated algorithm for the diagnosis and treatment of adults with acute bronchitis with a goal of reducing the antibiotic prescribing rate to near zero percent.

Detailed description

We will use a multi-modal implementation - including computerized decision support, reporting tools, and clinician feedback - and quality improvement techniques to ensure adherence to the algorithm and reduce the antimicrobial prescribing rate to near zero percent. The duration of the intervention will be 4 years.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDemonstration of near zero antibiotic prescribing for patients with acute bronchitisA controlled, continuously-monitored, implementation of an EHR-integrated diagnosis and treatment algorithm for acute bronchitis in a large, diverse primary care practice.

Timeline

Start date
2011-03-01
Primary completion
2014-06-01
Completion
2014-07-01
First posted
2010-11-15
Last updated
2017-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01240174. Inclusion in this directory is not an endorsement.